MEIS1 and posterior cortical atrophy: demonstrated that tumors with increased MEIS1 are potentially less aggressive, based on studies of LAPC-4 PCa cells expressing shRNA against MEIS1 and that tumors with lower levels of MEIS1 were at greater risk of biochemical recurrence and metastasis.